Cargando…
Applicability of the MASK-Air(®) App to Severe Asthma Treated with Biologic Molecules: A Pilot Study
MASK-air(®), a good practice of the DG Santé, has been fully validated in allergic rhinitis, but little is known about its applicability to asthmatics. We explored whether the MASK-air(®) application is applicable to patients with severe asthma. Severe asthmatics were proposed to use the MASK-air(®)...
Autores principales: | Benfante, Alida, Sousa-Pinto, Bernardo, Pillitteri, Gianluca, Battaglia, Salvatore, Fonseca, Joao, Bousquet, Jean, Scichilone, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569460/ https://www.ncbi.nlm.nih.gov/pubmed/36232771 http://dx.doi.org/10.3390/ijms231911470 |
Ejemplares similares
-
Asthma in the elderly: a different disease?
por: Battaglia, Salvatore, et al.
Publicado: (2016) -
Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients
por: Scichilone, Nicola, et al.
Publicado: (2013) -
The geriatric asthma: pitfalls and challenges
por: Benfante, Alida, et al.
Publicado: (2016) -
Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations
por: Scichilone, Nicola, et al.
Publicado: (2013) -
Prevalence of Arterial Hypertension and Characteristics of Nocturnal Blood Pressure Profile of Asthma Patients According to Therapy and Severity of the Disease: The BADA Study
por: Di Raimondo, Domenico, et al.
Publicado: (2020)